Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$16,364,810
+$523,143 QoQ
Shares Held
64,436
-0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#843
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BALDWIN WEALTH PARTNERS LLC/MA holds $27,785,455 across 7 Drug Manufacturers - General names. JNJ ranks #1 (58.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
64,436 | $16,364,810 | |
| 2 | NVS |
Novartis AG
|
27,679 | $4,337,852 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,669 | $2,013,466 | |
| 4 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 5 | ABBV |
AbbVie Inc.
|
6,976 | $1,755,440 | |
| 6 | AMGN |
Amgen Inc
|
2,413 | $873,795 | |
| 7 | PFE |
Pfizer Inc
|
23,579 | $567,782 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,364,810 | 64,436 | Shares | Defined | 2026-07-14 | |
| 2026-03-31 | $15,841,667 | 64,808 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $13,906,211 | 67,196 | Shares | Defined | 2026-01-07 | |
| 2025-09-30 | $12,582,230 | 67,858 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $10,950,036 | 71,686 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $12,258,561 | 73,918 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $12,196,816 | 84,337 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $14,611,329 | 90,160 | Shares | Other | 2024-10-16 | |
| 2024-06-30 | $13,663,329 | 93,482 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $15,096,387 | 95,432 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $15,439,203 | 98,502 | Shares | Other | 2024-01-08 | |
| 2023-09-30 | $15,569,548 | 99,965 | Shares | Other | 2023-10-10 | |
| 2023-06-30 | $16,857,384 | 101,845 | Shares | Other | 2023-07-14 | |
| 2023-03-31 | $16,022,350 | 103,370 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $18,258,189 | 103,358 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $5,467,495 | 33,469 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,356,632 | 35,810 | Shares | Other | 2022-07-18 | |
| 2022-03-31 | $6,386,659 | 36,036 | Shares | Other | 2022-04-13 | |
| 2021-12-31 | $5,985,910 | 34,991 | Shares | Other | 2022-01-14 | |
| 2021-09-30 | $5,607,441 | 34,721 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $5,740,859 | 34,848 | Shares | Other | 2021-07-30 | |
| 2021-03-31 | $5,720,694 | 34,808 | Shares | Other | 2021-04-08 | |
| 2020-12-31 | $5,455,891 | 34,667 | Shares | Other | 2021-01-12 | |
| 2020-09-30 | $5,163,455 | 34,682 | Shares | Other | 2020-10-16 | |
| 2020-06-30 | $4,905,454 | 34,882 | Shares | Other | 2020-07-21 | |
| 2020-03-31 | $4,637,542 | 35,366 | Shares | Other | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||